DB 2009(02) Adverse Incident Reports 2008.
Drug safety update: volume 2 issue 9, April 2009.
Hampton Review concludes regulator is confident, transparent and risk-aware [news release]. Plus: 'The Better Regulation Executive (BRE) has today published its report of the Hampton Implementation Review (HIR) into the Medicines and Healthcare products Regulatory Agency (MHRA).'
Interim UK regulatory route map for stem cell research and manufacture.
Launch of the e-MDA, the web-based UK-wide medical device alert.
Patient and public engagement strategy. April 2009 - March 2011.
Review of the EU variations regulation: European Commission consultation on draft guidelines.
Risk based inspections seminar. 22 May 2009. Venue: London. 'An opportunity to learn how the MHRA's risk based inspection strategy.'
[links to external webpages]